Whitehawk Therapeutics (WHWK) Cash from Operations (2010 - 2026)
Whitehawk Therapeutics (WHWK) posted quarterly Cash from Operations of 22208000.0 for Q1 2026, down 87.19% year-over-year from 173339284.21 in Q1 2025, and down 28.86% quarter-over-quarter from 17234000.0 in Q4 2025.
Powered by 
Analysis
Whitehawk Therapeutics (WHWK) Cash from Operations (2010 - 2026) Analysis & Trends
Whitehawk Therapeutics (WHWK) has reported Cash from Operations for 17 consecutive years, with 22208000.0 the latest figure, recorded in Q1 2026.
- In Q1 2026, Cash from Operations fell 87.19% year-over-year to 22208000.0; the TTM figure through Mar 2026 stood at 107777000.0 (down 108.22% YoY), while the FY2025 annual figure was 97433000.0, down 63.62% from the prior year.
- Cash from Operations retreated to 22208000.0 in Q1 2026 per WHWK's latest filing, from 17234000.0 in the prior quarter.
- Across five years, Cash from Operations topped out at 8195000.0 in Q3 2022 and bottomed at 52957000.0 in Q2 2025.
- Historically, Cash from Operations has averaged 16970235.29 across 5 years, with a median of 15378000.0 in 2025.
- Annual changes were most pronounced in 2022 — Cash from Operations soared 52.83% — and 2025, when it sank 478.32%.
- Whitehawk Therapeutics' Cash from Operations stood at 11310000.0 in 2022, then climbed by 14.73% to 9644000.0 in 2023, then plunged by 56.09% to 15053000.0 in 2024, then decreased by 14.49% to 17234000.0 in 2025, then dropped by 28.86% to 22208000.0 in 2026.
- Business Quant data shows WHWK's Cash from Operations at 22208000.0 in Q1 2026, 17234000.0 in Q4 2025, and 15378000.0 in Q3 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Operations (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn | 1.13 Bn |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn | 813.00 Mn |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn | -526.00 Mn |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - | -387.32 Mn |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn | 462.82 Mn |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn | 326.72 Mn |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - | 728.46 Mn |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn | -88.83 Mn |
| 10 | Whitehawk Therapeutics | 377.13 Mn | 377.13 Mn | - | -14.53 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -14.53 Mn |
| Mar 31, 2026 | -22.21 Mn |
| Dec 31, 2025 | -17.23 Mn |
| Sep 30, 2025 | -15.38 Mn |
| Jun 30, 2025 | -52.96 Mn |
| Mar 31, 2025 | -11.86 Mn |
| Dec 31, 2024 | -15.05 Mn |
| Sep 30, 2024 | -15.69 Mn |
| Jun 30, 2024 | -9.16 Mn |
| Mar 31, 2024 | -19.65 Mn |
| Dec 31, 2023 | -9.64 Mn |
| Sep 30, 2023 | -11.95 Mn |
| Jun 30, 2023 | -16.76 Mn |
| Mar 31, 2023 | -21.31 Mn |
| Dec 31, 2022 | -11.31 Mn |
| Sep 30, 2022 | -8.20 Mn |
| Jun 30, 2022 | -10.72 Mn |
| Mar 31, 2022 | -19.42 Mn |
| Dec 31, 2021 | -12.43 Mn |
| Sep 30, 2021 | -17.37 Mn |